Jacksonville, Florida
Colorectal cancer clinical trials in Jacksonville, FL
29 colorectal cancer studies are recruiting participants at sites in Jacksonville as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Jacksonville at a glance
- 29 studies are recruiting at a site in Jacksonville.
- By phase: Phase 1 (7), Phase 1/2 (6), Phase 2 (5), Phase 2/3 (1), Phase 3 (3), No phase (2), Observational (5). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (20), university, hospital or other (9).
- Most recent update to one of these records: November 12, 2026.
Studies recruiting in Jacksonville
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Mayo Clinic in Florida ( Site 0092)
- Registry record
- NCT06997497 · updated
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Florida
- Registry record
- NCT05969860 · updated
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
- Observational
- Ages 18 to 100
- All sexes
- Sponsor
- University of Florida
- Study site
- Mayo Clinic in Florida
- Registry record
- NCT05655494 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study site
- Baptist MD Anderson Cancer Center
- Registry record
- NCT05174169 · updated
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- Mayo Clinic, Jacksonville
- Registry record
- NCT06720987 · updated
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- A2 Biotherapeutics Inc.
- Study site
- Mayo Clinic Jacksonville
- Registry record
- NCT04981119 · updated
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Artios Pharma Ltd
- Study site
- Mayo Clinic (Florida)
- Registry record
- NCT04657068 · updated
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kura Oncology, Inc.
- Study site
- Mayo Clinic Comprehensive Cancer Center
- Registry record
- NCT06026410 · updated
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Mayo Clinic Hospital Jacksonville /ID# 274472
- Registry record
- NCT07023289 · updated
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- Mayo Clinic · Mayo Clinic Pharmacy
- Registry record
- NCT07222800 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT05919264 · updated
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Florida
- Registry record
- NCT06265285 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #78
- Registry record
- NCT05176483 · updated
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Florida
- Registry record
- NCT07285044 · updated
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT05877599 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- Mayo Clinic Cancer Center
- Registry record
- NCT06445062 · updated
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Amgen
- Study site
- Cancer Specialists of North Florida - Southpoint
- Registry record
- NCT06252649 · updated
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Cartography Biosciences
- Study site
- Mayo Clinic Florida
- Registry record
- NCT07321106 · updated
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Florida
- Registry record
- NCT05410977 · updated
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Xencor, Inc.
- Study site
- Xencor Investigative Site
- Registry record
- NCT05433142 · updated
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Phase 1
- Ages 18 to 100
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Mayo Clinic Jacksonville
- Registry record
- NCT06562192 · updated
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Study site
- Mayo Clinic Florida
- Registry record
- NCT06948448 · updated
Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial
- No phase
- Ages 18 to 44
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Florida
- Registry record
- NCT07618273 · updated
Intravital Microscopy in Human Solid Tumors
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic Florida
- Registry record
- NCT03823144 · updated
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- 858 Therapeutics, Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT06395519 · updated
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- Mayo Clinic in Florida
- Registry record
- NCT06349642 · updated
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Observational
- All ages
- All sexes
- Sponsor
- Massive Bio, Inc.
- Study site
- Massive Bio SYNERGY-AI site
- Registry record
- NCT03452774 · updated
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- A2 Biotherapeutics Inc.
- Study site
- Mayo Clinic
- Registry record
- NCT06682793 · updated
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- GI Innovation, Inc.
- Study site
- Mayo Clinic in Florida
- Registry record
- NCT05824975 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Jacksonville, FL on ClinicalTrials.gov.
Ask about studies near Jacksonville
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
132 studies recruiting across 62 cities.
Tampa
41 studies recruiting.
Orlando
23 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections